In this podcast, Dr. Christopher Flowers discusses research from the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition, including studies evaluating new treatments for diffuse large B-cell lymphoma and an overview of a session on improving equity in cancer clinical trials.
Read research from the January 2022 session of the ASCO Plenary Series, which highlights a study comparing 2 targeted therapies in treating advanced gastrointestinal stromal tumors (GISTs).
In this podcast, Dr. Norah Lynn Henry discusses new research and updates presented at the 2021 San Antonio Breast Cancer Symposium (SABCS) in early-stage breast cancer, metastatic breast cancer, and lymphedema.
Research from the first ASCO Plenary Series presentation has arrived. Read more about studies on using immunotherapy to treat metastatic melanoma and how technology can be used to find and manage symptoms during cancer treatment.
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting on brain tumors, esophageal cancer, and colorectal cancer.
In this webinar, experts discuss new research in gynecologic cancers, advanced melanoma, and cancer in people age 65 or older presented at the 2021 ASCO Annual Meeting.
In this webinar, experts discuss new research in genitourinary cancers presented at the 2021 ASCO Annual Meeting and the 2021 Genitourinary Cancers Symposium that highlighted advances in treating prostate, bladder, kidney, and testicular cancers.
Dr. Craig A. Portell discusses what CAR T-cell therapy is, how it works, what its common side effects are, and how it’s changing the landscape of how some types of cancers are treated.
Patient advocate Patty Spears discusses what eligibility criteria for cancer clinical trials are, why they’re important to cancer research, and how eligibility criteria are changing to include more people with cancer in clinical trials.
In Dr. Jyoti Patel’s first "From the Editor in Chief" post, she discusses what got her interested in caring for people with cancer, how she’s seen Cancer.Net evolve over the years, and what her goals are for the future of the site.
